Ivan Šitum, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients (NCT06811727) | Ivan Šitum, MD | 2025-05-01 |
Track Ivan Šitum, MD automatically
Every clearance here is in the API, with alerts when new ones post.